Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank63
Studio
Year-over-Year Change

Return on invested capital

Latest
-26.01%
↑ 47% vs avg
Percentile
P63
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-49.43%
Historical baseline
PeriodValueYoY Change
2025-26.01%+22.9%
2024-33.74%+0.5%
2023-33.91%+35.4%
2022-52.49%-128.4%
2021-22.98%-108.7%
2020-11.01%+86.7%
2019-82.87%+54.4%
2018-181.80%-
20170.00%-